|
FKTN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.51290000527382E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.62750000055301E-07 |
| Normal-vs-Stage2 |
1.387200E-04 |
| Normal-vs-Stage3 |
2.18710000110534E-08 |
| Normal-vs-Stage4 |
1.06410000033641E-07 |
| Stage1-vs-Stage2 |
6.961200E-01 |
| Stage1-vs-Stage3 |
1.150410E-01 |
| Stage1-vs-Stage4 |
6.973800E-02 |
| Stage2-vs-Stage3 |
4.769000E-01 |
| Stage2-vs-Stage4 |
2.621400E-01 |
| Stage3-vs-Stage4 |
5.385200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64469999841543E-08 |
| Normal-vs-AfricanAmerican |
1.689610E-02 |
| Normal-vs-Asian |
3.69620000000292E-05 |
| Caucasian-vs-AfricanAmerican |
3.396600E-01 |
| Caucasian-vs-Asian |
8.424400E-01 |
| AfricanAmerican-vs-Asian |
5.195800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4232000022929E-08 |
| Normal-vs-Female |
1.73520000035232E-07 |
| Male-vs-Female |
1.943830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73234999999439E-05 |
| Normal-vs-Age(41-60Yrs) |
8.21760000047078E-08 |
| Normal-vs-Age(61-80Yrs) |
1.73059999997172E-07 |
| Normal-vs-Age(81-100Yrs) |
2.421600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.808800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.960750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.348600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.851600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.762800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.544800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.251800E-02 |
| Classical-VS-Follicular |
2.652400E-01 |
| Classical-VS-Other |
1.852840E-01 |
| Classical-VS-Normal |
1.32860000001678E-06 |
| Tall-VS-Follicular |
1.527410E-01 |
| Tall-VS-Other |
7.893600E-01 |
| Tall-VS-Normal |
1.69120000004241E-07 |
| Follicular-VS-Other |
3.887200E-01 |
| Follicular-VS-Normal |
4.86060000004507E-06 |
| Other-VS-Normal |
3.684900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.19630000022997E-07 |
| Normal-vs-N1 |
4.29960000047913E-07 |
| N0-vs-N1 |
3.332600E-01 |
|
|
